Journal ArticleOPEN ACCESS

Altered left ventricular diastolic performance in oncologic patients treated with epirubicin.

Congestive heart failure (Greenwich, Conn.) (2007) 13(4) 215-220
DOI: 10.1111/j.1527-5299.2007.07122.x
11Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Anthracyclines confer an increased risk of cardiotoxicity. The authors evaluated left ventricular (LV) performance in patients treated with epirubicin. Sixty-eight patients with malignancies (study group), treated with epirubicin

Cite

CITATION STYLE

APA

Radulescu, D., Pripon, S., Parv, A., Duncea, C., & Ciuleanu, T. E. (2007). Altered left ventricular diastolic performance in oncologic patients treated with epirubicin. Congestive Heart Failure (Greenwich, Conn.), 13(4), 215–220. https://doi.org/10.1111/j.1527-5299.2007.07122.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free